SAj Blog Archives - Page 61 of 88

The Authors’ Own Words: Predictors of Substance Use Treatment Initiation and Engagement Among Adult and Adolescent Medicaid Recipients

Nov 26, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Predictors of Substance Use Treatment Initiation and Engagement Among Adult and Adolescent Medicaid Recipients

Bonnie K. Lind, PhD; Dennis McCarty, PhD; Yifan Gu, MS; Robin Baker, PhD; & K. John McConnell, PhD

Substance Abuse Vol. 40, Iss. 3, 2019

“This is the first analysis that looks at predictors of SUD treatment in both adolescents and adults in a Medicaid population. We found substantive differences in predictors of treatment initiation and engagement between adults and adolescents, including in gender and race groups, urban vs. rural residence, and presence of a psychiatric diagnosis. These findings suggest that efforts to improve treatment and engagement generally may need to differentiate strategies for adult and adolescent populations. In particular, efforts that may be successful for improving these measures for adult populations may be ineffective for adolescent populations, and, depending on the strategies, could exacerbate existing racial and gender disparities.“

The Authors’ Own Words: Patient Characteristics Associated with Treatment Initiation and Engagement Among Individuals Diagnosed with Alcohol and Other Drug Use Disorders in the Emergency Department and Primary Care Settings

Nov 25, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Patient Characteristics Associated with Treatment Initiation and Engagement Among Individuals Diagnosed with Alcohol and Other Drug Use Disorders in the Emergency Department and Primary Care Settings

Andrea H. Kline-Simon, MS; Scott P. Stumbo, MA; Cynthia I. Campbell, PhD, MPH; Ingrid A. Binswanger, MD, MPH, MS; Constance Weisner, DrPH, MSW; Irina V. Haller, PhD, MS; Rulin C. Hechter, MD, PhD; Brian K. Ahmedani, PhD, LMSW; Gwen T. Lapham, PhD, MPH, MSW; Amy M. Loree, PhD, Stacy A. Sterling, DrPH, MSW; & Bobbi Jo H. Yarborough, PsyD

Substance Abuse Vol. 40, Iss. 3, 2019

“Based on these study findings, it may be beneficial for clinicians in the ED setting to focus extra attention on younger patients and non-White race/ethnicities; while clinicians in primary care settings may need to spend extra time with older patients and those with a medical comorbidity, to encourage treatment initiation among these groups, though there is also still a need for broad screening in both settings. As the ED and primary care settings are often the first line of care for patients struggling with an AOD use disorder, addressing patients’ needs in these settings as they are identified may help them access and engage in treatment.“

The Authors’ Own Words: The Prevalence of HEDIS Initiation and Engagement in Treatment among Patients with Cannabis Use Disorders in Seven U.S. Health Systems

Nov 25, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

The Prevalence of HEDIS Initiation and Engagement in Treatment among Patients with Cannabis Use Disorders in Seven U.S. Health Systems

Constance Weisner, DrPH, MSW; Cynthia I. Campbell, PhD, MPH; Andrea Altschuler, PhD; Bobbi Jo H. Yarborough, PsyD; Gwen T. Lapham, PhD, MPH, MSW; Ingrid A. Binswanger, MD, MPH, MS; Rulin C. Hechter, MD, PhD; Brian K. Ahmedani, PhD, LMSW; Irina V. Haller, PhD, MS; Stacy A. Sterling, DrPH, MSW; Dennis McCarty, PhD; Derek D. Satre, PhD; & Andrea H. Kline-Simon, MS

Substance Abuse Vol. 40, Iss. 3, 2019

“This observational cohort study of 15,202 patients with a cannabis use disorder (CUD) from seven U.S. healthcare systems is the first known study to describe rates of HEDIS-defined alcohol and other drug use disorder (AOD) measures for initiation and engagement in treatment among patients with a newly diagnosed CUD. For these patients, rates of initiation and engagement were low, with considerable variation across index diagnosis setting, AOD comorbidity at index diagnosis, and patient characteristics. Greater adherence to these system-level treatment measures will likely require strong leader and provider partnerships to improve recognition of and linkage to evidence-based treatment for CUD, particularly for those patients with less AOD severity who could still benefit from treatment.“

Substance Abuse journal Volume 40 | Issue 2

Nov 22, 2019 by AMERSA

The Authors’ Own Words for Volume 40, Issue 2 have come to end. We always enjoy reading what the authors have to say about their work and we hope that you do too!

We think that this was a great issue of SAj. If you haven’t read it yet, you still can! Substance Abuse journal, Vol. 40, Iss. 2

The most viewed piece of work in this issue was:

Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?

Molly Doernberg BA; Noa Krawczyk BA; Deborah Agus JD; & Michael Fingerhood MD

with 361 views (and counting!)

The Authors’ Own Words: Substance use is independently associated with pneumonia severity in persons living with HIV

Nov 22, 2019 by AMERSA

The Authors’ Own Words:

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

Substance use is independently associated with pneumonia severity in persons living with HIV

Sarah E. Jolley, MD, MSc & David A. Welsh, MD

Substance Abuse Vol. 40, Iss. 2, 2019

“Our manuscript highlights the impact of illicit drug use on pneumonia severity in people living with HIV/AIDS. It shows that illicit drug use is common and that use of intravenous drugs or inhalational crack/cocaine is associated with increased pneumonia severity. Interestingly, use of marijuana is associated with less severe pneumonia and marijuana use mitigates the negative effect of alcohol on pneumonia risk. Finally, our manuscript describes a significant interaction between patient sex and alcohol use on pneumonia severity with women with an alcohol use disorder experiencing more severe pneumonia. We feel our results will aid in risk stratification of pneumonia patients and highlight a high risk group for targeted hospital-based interventions aimed at addressing addiction.“